We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Deadline to Phase Out CFC Inhalers Approaching
Deadline to Phase Out CFC Inhalers Approaching
December 12, 2008
Armstrong Pharmaceuticals is the only manufacturer that has not transitioned from albuterol metered-dose inhalers using chlorofluorocarbon (CFC) propellants to hydrofluroalkane- (HFA) propelled albuterol inhalers, the FDA says.